Topics
ONE TIME EVENT
LIFE Changing Moments for Women Living with HR+ HER2- advanced breast cancer: MONALEESA 3
PSMO 19TH MIDYEAR CONVENTION
Raising Standards in HR+/HER2-mBC with CDK4/6 Inhibitors: Measuring Recent Progress
PSMO 19TH MIDYEAR CONVENTION
Role of Biosimilars in Value-based Medicine in Oncology: Experience with Biosimilar Trastuzumab